Consultancy 10x
What do we do?

We build strategies in Market Access, health policy and medical affairs for a pharmacist to prepare, launch and succeed in the Latin American pharmaceutical market with a efficient implementation of the plan

About us?

We are a group of strategists in the pharmaceutical sector trained in medicine, health economics and administration with extensive experience in the entry, optimization and development of Market Access plans in Latin America.

Why buy this service?

The outlook for entering the pharmaceutical markets is increasingly challenging; Regulatory issues, achieving reimbursement, and how to approach payers and other decision makers presents big challenges. A deep strategic, empirical and technical knowledge is required to achieve it successfully. For this reason, we have built a package of solutions for your organization.

  • Initial diagnostic
  • Opportunity identification
  • Construction of the value message
  • Trading models
  • Field implementation

Initial diagnostic

Services: Mapping and ranking of markets.

Opportunity identification

Services: Mapping, payer segmentation, reimbursement analysis.

Construction of the value message

Services: value proposition, generation of evidence

Trading models

Services: structuring of contracting models, pricing

Field implementation

Health Policy

The growing competition for therapeutic options and health costs have made health systems, especially in Latin America, generate policies and mechanisms that promote sustainability and the best outcomes for patients. It is necessary to structure and implement strategies that can reconcile access to technologies and subsequent health outcomes with financial sustainability. We have the vision of public policy makers in Latin America.

  • Campaigns and tools
  • Organizational development
  • Frameworks
Campaigns and tools

Services: reports and events

Organizational development

Service: training


Services: report with strategy and implementation plan

Medical affairs

The identification of shortcomings and the generation of scientific evidence is key to building the value proposition of a health technology. It is key that the medical team build the correct arguments, is in contact with the real need of insurers and providers and can integrate with other departments to achieve impact results in Market Access.

  • Medical strategy
  • Generation of evidence and dissemination of information
  • strategy implementation

Medical strategy

Generation of evidence and dissemination of information

Strategy implementation

If you want to purchase this service
Schedule a video call or write us